You have probably seen the claim somewhere online:
“Europe bans thousands of cosmetic ingredients. The US bans hardly any.”
It makes for an excellent headline.
It also leaves out most of the interesting part.
Europe and the United States genuinely do regulate cosmetics differently. An ingredient can face restrictions in one market that do not exist in the other. Labels can look different. Products can require reformulation before crossing the Atlantic.
But that does not mean every ingredient permitted in the US is dangerous, or that every cosmetic sold in Europe has received a government stamp of approval.
The real explanation is more nuanced, and considerably more useful.
The biggest difference is not the number of banned ingredients
It is how the two systems are built.
In the European Union, cosmetics are governed by a single Cosmetics Regulation that applies across member states.
Before a cosmetic product reaches the EU market, it must have a designated Responsible Person and undergo an expert scientific safety assessment. Product information is also submitted through the EU Cosmetic Products Notification Portal.
The regulation contains detailed annexes covering substances that are prohibited, restricted, or permitted only for particular functions or at particular concentrations.
The United States takes a different approach.
Most cosmetic products and ingredients do not require FDA approval before they are sold. Color additives are an important exception.
Instead, the company marketing the cosmetic is legally responsible for making sure it is safe when used as intended or in a reasonably foreseeable way.
That distinction is important.
“Not prohibited by the FDA” does not mean “approved by the FDA.”
Those are very different statements.
Then there is the question of hazard versus actual exposure
This is where the debate gets more interesting.
Imagine an ingredient that can cause harm at a sufficiently high dose.
That tells us something about its hazard.
But it does not, by itself, tell us the risk posed by a cosmetic containing a tiny amount of that ingredient under normal conditions of use.
Concentration matters.
Exposure matters.
Whether the product is rinsed off or left on the skin matters.
Where it is applied matters.
How frequently it is used matters.
The EU absolutely considers exposure and risk when assessing cosmetic safety. But its legislation also contains specific mechanisms triggered by certain hazard classifications.
One important example is substances classified as carcinogenic, mutagenic, or toxic for reproduction, often shortened to CMR substances. As a general rule, substances falling into specified CMR categories are prohibited from cosmetics in the EU, although the regulation allows limited exceptions when strict conditions are met.
That means a chemical classification made under wider European chemicals legislation can have a direct regulatory consequence for cosmetics.
The US system does not contain an identical automatic mechanism.
Instead, US law requires the finished cosmetic to be safe under its intended and customary conditions of use, and manufacturers must maintain adequate evidence supporting that safety.
This is one reason simply comparing two “banned ingredient” lists can be misleading.
The lists are not necessarily answering the same question.
A surprisingly good example is sunscreen
Sunscreen illustrates just how different two regulatory systems can become even when both are trying to protect consumers.
In the European Union, sunscreen is regulated as a cosmetic.
UV filters used in cosmetics must be scientifically assessed and authorized for use.
In the United States, sunscreen products are regulated as over the counter drugs.
That means sunscreen active ingredients follow an entirely different US regulatory pathway.
For years, this resulted in European consumers having access to some modern UV filters that were unavailable in American sunscreens.
That did not necessarily mean Europe considered those ingredients safe while America considered them dangerous.
Sometimes the difference was simply that the ingredient had moved through one regulatory pathway but not the other.
In June 2026, the FDA added bemotrizinol as a permitted sunscreen active ingredient, the first new active ingredient added to the US over the counter sunscreen monograph in decades.
Same ingredient.
Different regulatory systems.
Different timelines.
That is a far more useful explanation than “Europe allows better sunscreen.”
Fragrance tells another part of the story
Fragrance is another area where regulation can look noticeably different on opposite sides of the Atlantic.
Cosmetics in both markets generally list their ingredients, but fragrance mixtures have historically been able to appear under collective terms such as “fragrance” or “parfum.”
The EU also requires certain fragrance allergens to be individually identified on cosmetic labels above specified concentrations.
Those requirements have been expanded significantly, with new EU labeling provisions entering their implementation period.
The purpose is practical.
If someone already knows they are allergic to a particular fragrance component, individual labeling can help them avoid it.
The United States is moving in a similar direction.
Under the Modernization of Cosmetics Regulation Act, commonly known as MoCRA, Congress directed the FDA to establish fragrance allergen labeling requirements.
So even here, the story is not simply “Europe regulates it and America does not.”
The systems are evolving, sometimes toward similar goals, but at different speeds and through different legal mechanisms.
The US system has also changed considerably
A lot of online comparisons still describe American cosmetic regulation as though nothing has changed since the twentieth century.
That is increasingly outdated.
MoCRA represented the largest expansion of FDA authority over cosmetics since the Federal Food, Drug, and Cosmetic Act was enacted in 1938.
Among other things, the law introduced or strengthened requirements around:
Safety substantiation
Companies must maintain records supporting the safety of their cosmetic products.
Product listing
Responsible persons generally must list marketed cosmetic products and their ingredients with the FDA.
Facility registration
Many cosmetic manufacturing and processing facilities must register with the FDA.
Serious adverse events
Companies have reporting obligations when serious adverse events associated with cosmetics occur.
FDA enforcement
The FDA gained additional records access and mandatory recall authority in defined circumstances.
That still does not make the American framework identical to Europe's.
But it does make the popular idea that US cosmetics are essentially unregulated increasingly difficult to defend.
So is European skincare safer?
Here is the slightly unsatisfying but important answer:
You cannot determine whether a cosmetic is safe simply by looking at the country in which it is sold.
A substance can be hazardous at one concentration and safely used at another.
An ingredient may be acceptable in a rinse off product but restricted in another type of application.
A regulatory restriction can change as new evidence becomes available.
And two regulators looking at similar scientific information can operate under different laws, classification systems, evidentiary requirements, and timelines.
European regulation is generally more prescriptive about which ingredients may be used and under what conditions.
The American system has historically placed more responsibility directly on manufacturers, backed by FDA enforcement, although MoCRA has introduced considerably more federal oversight.
Neither fact can be reduced to a viral graphic comparing two numbers.
The useful question is different
Instead of asking:
“Is this ingredient banned somewhere?”
A better set of questions is:
What does the ingredient actually do?
At what concentration is it being used?
Is the product rinsed off or left on the skin?
What is the expected exposure?
What does the available safety evidence show?
Are there restrictions on how the ingredient can be used?
And is the finished formula appropriate for its intended use?
That is less dramatic than a list of “toxic ingredients.”
It is also much closer to how cosmetic safety actually works.
Because the ingredient list on the back of your hand cream is not simply a collection of good ingredients and bad ingredients.
It is a formula.
And context matters.
The takeaway
Europe and the United States disagree on some cosmetic ingredients because they operate different regulatory systems, not because one side has discovered a secret list of dangerous chemicals that the other has somehow missed.
The EU tends to use a more centralized and prescriptive framework, including detailed restrictions, scientific safety assessments, and specific hazard based regulatory triggers.
The US traditionally relied more heavily on manufacturer responsibility and post market FDA authority, although MoCRA has significantly expanded federal oversight.
Understanding that difference makes ingredient labels considerably more interesting.
It also makes them considerably less frightening.
And perhaps that is the point.
Good cosmetic formulation should not rely on fear.
It should rely on evidence, appropriate use, thoughtful formulation, and transparency about what is actually inside the product.
This article is provided for general educational purposes only and is not legal, regulatory, or medical advice. Cosmetic regulations and ingredient restrictions evolve over time, and requirements may vary by product, concentration, intended use, and jurisdiction.